MedTrace Logo

Functional Lung Imaging With DECT and 4DCT

NCT04702607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-11-05

No results posted yet for this study

Summary

The basic premise of this pilot study is to enroll 40 patients over 3 years who have Stage II, III, or IV non-small cell lung cancer and are planned for definitive treatment with concurrent chemoradiation where a contrast enhanced 4DCT is planned.

Conditions

  • Non Small Cell Lung Cancer

Interventions

PROCEDURE

contrast enhanced 4DCT

Functional Lung Imaging with DECT and 4DCT

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Steven Feigenberg, MD · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-02
Primary Completion
2024-10-05
Completion
2024-10-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04702607 on ClinicalTrials.gov